These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30587876)

  • 1. A pediatric case with parvovirus B19-associated uveitis without autoantibody formation.
    Ito T; Hoshina T; Mizuki K; Fukuda T; Ishibashi S; Kusuhara K
    Nagoya J Med Sci; 2018 Nov; 80(4):611-614. PubMed ID: 30587876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein.
    Tzang BS; Lee YJ; Yang TP; Tsay GJ; Shi JY; Tsai CC; Hsu TC
    Clin Chim Acta; 2007 Jul; 382(1-2):31-6. PubMed ID: 17451664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.
    Kerr JR
    J Clin Pathol; 2016 Apr; 69(4):279-91. PubMed ID: 26644521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties.
    Lunardi C; Tiso M; Borgato L; Nanni L; Millo R; De Sandre G; Severi AB; Puccetti A
    Eur J Immunol; 1998 Mar; 28(3):936-48. PubMed ID: 9541589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis.
    Heinz C; Plentz A; Bauer D; Heiligenhaus A; Modrow S
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):999-1004. PubMed ID: 15906067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies following parvovirus B19 infection.
    Kerr JR; Boyd N
    J Infect; 1996 Jan; 32(1):41-7. PubMed ID: 8852550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unscrambling the role of human parvovirus B19 signaling in systemic autoimmunity.
    Tsay GJ; Zouali M
    Biochem Pharmacol; 2006 Nov; 72(11):1453-9. PubMed ID: 16764828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses.
    Page C; François C; Goëb V; Duverlie G
    J Clin Virol; 2015 Nov; 72():69-74. PubMed ID: 26433772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human parvovirus B19 infection and autoimmunity.
    Lunardi C; Tinazzi E; Bason C; Dolcino M; Corrocher R; Puccetti A
    Autoimmun Rev; 2008 Dec; 8(2):116-20. PubMed ID: 18700174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontal lobe seizures and uveitis associated with acute human parvovirus B19 infection.
    Hsu D; Sandborg C; Hahn JS
    J Child Neurol; 2004 Apr; 19(4):304-6. PubMed ID: 15163099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic manifestations of Parvovirus B19 infections].
    Sève P; Ferry T; Charhon A; Calvet A; Broussolle C
    Rev Med Interne; 2004 Oct; 25(10):740-51. PubMed ID: 15471600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and biological manifestations in primary parvovirus B19 infection in immunocompetent adult: a retrospective study of 26 cases].
    Parra D; Mekki Y; Durieu I; Broussolle C; Sève P
    Rev Med Interne; 2014 May; 35(5):289-96. PubMed ID: 23773900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway?
    Aslanidis S; Pyrpasopoulou A; Kontotasios K; Doumas S; Zamboulis C
    Eur J Intern Med; 2008 Jul; 19(5):314-8. PubMed ID: 18549931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Observations on human parvovirus B19 infection diagnosed in 2011].
    Mihály I; Trethon A; Arányi Z; Lukács A; Kolozsi T; Prinz G; Marosi A; Lovas N; Dobner IS; Prinz G; Szalai Z; Pék T
    Orv Hetil; 2012 Dec; 153(49):1948-57. PubMed ID: 23204301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis.
    Kerr JR; Cunniffe VS; Kelleher P; Coats AJ; Mattey DL
    J Med Virol; 2004 Sep; 74(1):147-55. PubMed ID: 15258981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhabdomyolysis associated with human parvovirus B19 infection in a patient with Fukuyama-type congenital muscular dystrophy.
    Ishikawa A; Yoto Y; Ohya K; Tsugawa T; Tsutsumi H
    J Child Neurol; 2014 Jul; 29(7):977-9. PubMed ID: 23594821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor?
    Stepan H; Wallukat G; Schultheiss HP; Faber R; Walther T
    J Reprod Immunol; 2007 Apr; 73(2):130-134. PubMed ID: 17150255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory status epilepticus owing to human parvovirus B19 encephalitis in a child.
    Erol I; Alehan F; Yalçin K
    J Child Neurol; 2006 Sep; 21(9):820-2. PubMed ID: 16970896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of parvovirus B19 infection in childhood acute lymphoblastic leukemia.
    Heegaard ED; Jensen L; Hornsleth A; Schmiegelow K
    Pediatr Hematol Oncol; 1999; 16(4):329-34. PubMed ID: 10407869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.